Product Information
TRIAMCINOLONE 0.1% CREAM is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.1020 per GM under NDC 45802006435. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AT.
Strength
1 mg/g
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802006435
Classification
Generic
Dosage Form
CREAM
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
TRIAMCINOLONE ACETONIDEApproval Type
Generic (ANDA)
FDA Application
ANDA086413FDA Approved
Before 1982
TE Code
AT
On Market Since
9/28/2006
Pharmacological Classes
Price Statistics
The NADAC for TRIAMCINOLONE 0.1% CREAM has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 49.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1020 per GM |
|---|---|
| All-time high | $0.2022 (Dec 11, 2013) |
| All-time low | $0.0993 (Jul 22, 2026) |
| 52-week high | $0.1276 |
| 52-week low | $0.0993 |
| Median price | $0.1411 |
| Average price | $0.1458 |
| Largest weekly change | +40.9% (Jun 19, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 73% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Padagis Israel Pharmaceuticals Ltd manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Triamcinolone Acetonide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TRIAMCINOLONE 0.1% CREAM?
The current National Average Drug Acquisition Cost (NADAC) for TRIAMCINOLONE 0.1% CREAM, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.1020 per GM (NDC 45802006435), effective Sep 30, 2026.
How has the price of TRIAMCINOLONE 0.1% CREAM changed over time?
Over the history we have for it, the NADAC for TRIAMCINOLONE 0.1% CREAM has declined 49.6%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TRIAMCINOLONE 0.1% CREAM?
Since Nov 28, 2013, the NADAC for TRIAMCINOLONE 0.1% CREAM has ranged from a low of $0.0993 (Jul 22, 2026) to a high of $0.2022 (Dec 11, 2013), with a median of $0.1411 per GM.
Are there cheaper alternatives to TRIAMCINOLONE 0.1% CREAM?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TRIAMCINOLONE 0.1% CREAM, is $0.0273 per GM — about 73% below TRIAMCINOLONE 0.1% CREAM.
Who manufactures TRIAMCINOLONE 0.1% CREAM?
TRIAMCINOLONE 0.1% CREAM (NDC 45802006435) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.